Press Release: Izun Pharmaceuticals Announces Positive Results from Phase 2 Randomized Trial in Diabetic Foot Ulcers Company Plans to Meet with FDA to Discuss Filing Strategy for Approval – Quote: Izun Pharmaceuticals Corporation (?Izun?, the ?Company?, izunpharma.com), a clinical stage company focused on developing high efficacy products based on botanical sources announced today that it has successfully completed a multicenter randomized, controlled trial comparing IZN-6D4, a topical pharmaceutical gel, to a matching active hydrogel placebo to treat diabetic foot ulcers. The study was conducted at seven centers in Israel in 82 patients.
Visit site:
IZN-6D4 for diabetic foot ulcers